As IL-22 was recently shown to protect intestinal stem cells against genotoxic stress and thus against colon cancer (17), we suggest that the susceptibility for oral and esophageal squamous cell carcinoma may result from the combination of persistent inflammation with the lack of protective function of IL-22. Here, IL22 is linked to colonic neoplasm.